Ligand validation:4E3X

PRO: PROLINE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4E3X_PRO_B_601	93%	45%	0.062	0.956	0.9	1.26	1	2	0	0	100%	1
4E3X_PRO_A_601	81%	46%	0.074	0.925	0.81	1.3	1	1	0	0	100%	1
4E3X_PRO_B_603	76%	44%	0.087	0.923	0.86	1.34	1	1	1	0	100%	1
4E3X_PRO_A_604	60%	46%	0.109	0.894	0.86	1.24	1	1	1	0	100%	1
4E3X_PRO_A_602	43%	44%	0.109	0.832	0.81	1.37	-	2	0	0	100%	1
4E3X_PRO_A_603	32%	44%	0.203	0.878	0.83	1.36	1	2	0	0	100%	1
4E3X_PRO_B_602	14%	44%	0.166	0.715	0.85	1.33	1	2	0	0	100%	1
4N1M_PRO_A_202	100%	55%	0.042	0.992	0.49	1.24	-	1	0	0	100%	1
5MC1_PRO_A_504	96%	43%	0.071	0.978	0.84	1.38	-	2	0	0	100%	1
2AMF_PRO_C_4331	93%	52%	0.079	0.975	0.67	1.17	-	1	3	0	100%	1
7FAK_PRO_A_902	93%	47%	0.081	0.977	0.84	1.22	1	1	0	0	100%	1
7F99_PRO_A_1909	93%	41%	0.093	0.989	0.71	1.61	-	2	0	0	100%	0.93

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.